Ypsomed founder Willy Michel awarded Prix Suisse 2025
Select your language
Generated with artificial intelligence.
Listening:
Ypsomed founder Willy Michel awarded Prix Suisse 2025
Ypsomed founder Willy Michel has received the Prix Suisse 2025 in Bern. The organisation Initiative Schweiz honoured Michel for his services as an entrepreneur, innovator and patron. Federal Councillor Albert Rösti presented him with the award.
+Get the most important news from Switzerland in your inbox
Michel has had a lasting impact on medical technology with his companies Ypsomed and Disentronic, according to Initiative Schweiz am Sonntag. His pioneering work in insulin delivery improved the lives of millions of people worldwide, it said.
Michel described the award as a special recognition of his life’s work.
At the award ceremony on Saturday, human rights lawyer Amal Clooney spoke to around 400 representatives from politics and business about responsibility, justice and freedom of the press. Clooney has been campaigning for victims of war crimes, genocide and abuse of power for years. She is a UN special adviser.
The non-profit organisation Initiative Switzerland has been presenting the award since 2021, with previous winners including musician Büne Huber and skier Marco Odermatt.
+ Patent Ochsner frontman Büne Huber awarded Prix Suisse 2024
Translated from German by DeepL/ts
We select the most relevant news for an international audience and use automatic translation tools to translate them into English. A journalist then reviews the translation for clarity and accuracy before publication.
Providing you with automatically translated news gives us the time to write more in-depth articles. The news stories we select have been written and carefully fact-checked by an external editorial team from news agencies such as Bloomberg or Keystone.
If you have any questions about how we work, write to us at english@swissinfo.ch
External Content
In compliance with the JTI standards
More: SWI swissinfo.ch certified by the Journalism Trust Initiative
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.